Internal Medicine, Hematology & Oncology · Dallas, TX
NPI
1285677138
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7777 Forest Ln, Bldg D, Suite 400
Dallas, TX, 75230
Phone (972) 566-7790
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
182,765 services
Medicare patients, 2024
676
Average age 71
Drug cost, 2024
$4.5M
1,317 prescriptions
Company payments, 2025
$80.61
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vikas Bhushan was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 36,180 times for 16 patients. In total Vikas Bhushan billed 182,765 services in 215 codes, and Medicare paid $2.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 36,180 | 16 | $0.22 | $7,986 |
| J9025 Injection, azacitidine, 1 mg | Office | 18,400 | 13 | $0.28 | $5,117 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,500 | 11 | $44.65 | $380K |
| J1756 Injection, iron sucrose, 1 mg | Office | 7,800 | 17 | $0.17 | $1,315 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,600 | 19 | $0.11 | $721 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,240 | 12 | $29.02 | $65K |
| 99232 Hospital E&M - Subsequent | Facility | 1,958 | 210 | $59.73 | $117K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,484 | 47 | $0.09 | $132 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 880 | 30 | $0.25 | $221 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 792 | 45 | $0.07 | $56.98 |
| 80053 Clinical Chemistry | Office | 652 | 270 | $10.34 | $6,739 |
| 83735 Clinical Chemistry | Office | 646 | 270 | $6.56 | $4,238 |
| 83615 Clinical Chemistry | Office | 645 | 269 | $5.91 | $3,813 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 560 | 23 | $0.68 | $383 |
| 83521 Immunoassay | Office | 488 | 115 | $16.86 | $8,228 |
By year: 2022 $2.7M for 207,898 services; 2023 $2.5M for 162,278 services; 2024 $2.7M for 182,765 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 652 | 270 | $10.34 | $6,739 |
| 83735 Clinical Chemistry | 646 | 270 | $6.56 | $4,238 |
| 83615 Clinical Chemistry | 645 | 269 | $5.91 | $3,813 |
| 83521 Immunoassay | 488 | 115 | $16.86 | $8,228 |
| 85025 Blood Count | 465 | 209 | $7.60 | $3,532 |
| 36415 Venipuncture Blood Collection | 432 | 212 | $8.65 | $3,737 |
| 85007 Blood Count | 195 | 111 | $3.72 | $725 |
| 85027 Blood Count | 195 | 111 | $6.34 | $1,236 |
| 82787 Immunoassay | 176 | 27 | $7.86 | $1,383 |
| 82728 Clinical Chemistry | 63 | 46 | $13.36 | $842 |
Medicare prescription drug claims, 2024
In 2024, the drug Vikas Bhushan prescribed most often to Medicare patients was Acyclovir, with 134 prescriptions and refills. In total Vikas Bhushan wrote 1,317 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 134 | 212 | 38 | $1,783 |
| Prednisone Generic | 78 | 150 | 25 | $447 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 62 | 62 | 30 | $1,774 |
| Gabapentin Generic | 48 | 74 | 14 | $892 |
| Potassium Chloride Generic | 43 | 61 | 15 | $760 |
| Pregabalin Generic | 37 | 49 | 13 | $1,289 |
| Pomalyst Pomalidomide | 35 | 35 | Under 11 | $619K |
| Pantoprazole Sodium Generic | 32 | 72 | 13 | $334 |
| Jakafi Ruxolitinib Phosphate | 29 | 29 | Under 11 | $469K |
| Ayvakit Avapritinib | 28 | 28 | Under 11 | $1.1M |
| Alprazolam Generic | 26 | 30 | Under 11 | $99.39 |
| Temazepam Generic | 25 | 25 | Under 11 | $213 |
| Venclexta Venetoclax | 24 | 24 | Under 11 | $144K |
| Trazodone Hcl Generic | 24 | 24 | Under 11 | $88.38 |
| Alendronate Sodium Generic | 22 | 35 | Under 11 | $98.96 |
Brand drugs: - claims; generic drugs: 1,032 claims; opioid claims: 103.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vikas Bhushan $80.61 ($80.61 in general payments such as food, travel and fees) from 4 companies. The largest payer was Astellas Pharma US Inc with $49.66.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.